Latest Alcohols Stories
TOKYO, September 3, 2012 /PRNewswire/ -- - QVA149 demonstrated superior bronchodilation compared to indacaterol 150 mcg, glycopyrronium 50 mcg, salmeterol/fluticasone 50/500 mcg BID, OL tiotropium 18 mcg and placebo[1,2] - Seebri(R) Breezhaler(R) (glycopyrronium bromide) demonstrated rapid, sustained bronchodilation and reduced exacerbations similar to OL tiotropium 18 mcg in GLOW pooled data analysis[3,4]...
BEVERLY HILLS, Calif., Aug. 31, 2012 /PRNewswire/ -- Eaton Scientific Systems, Ltd. ("Eaton Scientific" or the "Company"), a wholly owned subsidiary of Pristine Solutions, Inc. (OTCQB: PRTN) is pleased to provide this update detailing recent comments made by Dr. Hootan Melamed, whose family's Beverly Hills, CA based Rox San Pharmacy is the original compounding Pharmacy for Tropine 3, a Novel indication of Homatropine in oral suspension. Dr. Melamed filed the Patent for the drug's new...
TOKYO, August 30, 2012 /PRNewswire/ -- - SPARK demonstrated QVA149 statistically significantly reduced rate of moderate-to-severe exacerbations compared to glycopyrronium 50 mcg[1] - Study showed QVA149 statistically significantly reduced overall exacerbation rates compared to glycopyrronium 50 mcg and open-label tiotropium 18 mcg[1] - SPARK is the final study of the IGNITE Phase III clinical trial program intended for...
RARITAN, N.J., Aug. 29, 2012 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for NUCYNTA(® )ER (tapentadol) extended-release tablets, an oral analgesic taken twice daily, for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time....
RALEIGH, N.C., Aug. 29, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Stifel Nicolaus 2012 Healthcare Conference. The presentation is scheduled for Wednesday, September 5, 2012 at 8:00 a.m. Eastern Time, at the Four Seasons Hotel in Boston. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) Dr. Sirgo will focus on BDSI's progress with...
Berkeley Lab study links healthy micronutrient intake with reduced DNA fragmentation A new study led by scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) found that a healthy intake of micronutrients is strongly associated with improved sperm DNA quality in older men. In younger men, however, a higher intake of micronutrients didn't improve their sperm DNA. In an analysis of 80 healthy male volunteers between 22 and 80 years of age, the...
BEVERLY HILLS, Calif., Aug. 27, 2012 /PRNewswire/ -- Pristine Solutions, Inc. (OTCQB: PRTN) (OTCBB: PRTN) ("Pristine Solutions" or the "Company") is pleased to announce that the Company has completed the acquisition of Eaton Scientific Systems, Ltd., a biomedical product development company focused on women's health solutions ("Eaton Scientific"). Eaton Scientific has identified, developed, and filed a patent for a novel indication of an existing FDA approved drug, homatropine, for...
GREENSBORO, N.C., Aug. 27, 2012 /PRNewswire/ -- Merz, Inc. (U.S. affiliate of Merz Pharma Group) today announced the acquisition of CUVPOSA(®) (glycopyrrolate) oral solution for pediatric chronic severe drooling associated with neurologic conditions such as cerebral palsy. Cerebral palsy (CP) is a lifelong condition that encompasses a group of non-progressive, neurological disorders affecting body movement and muscle coordination. According to previous estimates from a study...
Purchase "Medically Tested" products from a dermatologist to ensure stability and effectiveness. You may be buying product that will produce little or no results. Las Vegas, Nevada (PRWEB) August 23, 2012 Dr. F. Victor Rueckl, of Lakes Dermatology, Las Vegas, Nevada is making sure that his patients know what their getting when they buy over-the-counter products. "Products that are medically tested means often times, skin biopsies are done pre and post use. This shows, down...
ENGLEWOOD, Colo., Aug. 13, 2012 /PRNewswire/ -- Gevo, Inc. (NASDAQ: GEVO), a leading renewable chemicals and next-generation biofuels company, announced today that the Federal Circuit Court of Appeals granted Gevo's motion to stay a status quo order entered on July 6(th) by the U.S. District Court in Delaware. The status quo order had prohibited Gevo from selling bio-isobutanol to the automotive fuels market pending Butamax(TM) Advanced Biofuels, LLC's (Butamax) appeal of the District...
